SCHEMBL31133663

SCHEMBL31133663

Cn1c(=O)c(C#N)c(N2CCC(Oc3ccccc3C(F)(F)F)CC2)c2nc(Cl)ccc21

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 14/20 0.56
▸ TTR P02766 2/20 0.45
▸ RBP4 P02753 1/20 0.45
▸ DGKA P23743 1/20 0.42
▸ DGKZ Q13574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23526885 1.00 SCD (0.56) SCDTTRRBP4DGKADGKZ
SCHEMBL23527152 0.90 SCD (0.46) SCDTTRRBP4DGKADGKZ
SCHEMBL31133573 0.90 SCD (0.46) SCDTTRRBP4DGKADGKZ
SCHEMBL31133649 0.89 SCD (0.44) SCDDGKADGKZ
SCHEMBL23526837 0.89 SCD (0.44) SCDDGKADGKZ
SCHEMBL23526978 0.89 SCD (0.53) SCDDGKADGKZ
SCHEMBL31133806 0.89 SCD (0.53) SCDDGKADGKZ
SCHEMBL23527026 0.88 SCD (0.45) SCDDGKADGKZ
SCHEMBL23526832 0.88 SCD (0.45) SCDDGKADGKZ
SCHEMBL31133787 0.88 SCD (0.45) SCDDGKADGKZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081523-B1 SUBSTITUTED BICYCLIC PIPERIDINE DERIVATIVES USEFUL AS T CELL ACTIVATORS BRISTOL MYERS SQUIBB CO (US) 2024-12-25 — — EP claimed
CN-114901660-B Substituted bicyclic compounds useful as T cell activators 百时美施贵宝公司 2024-10-15 — — CN claimed
CN-114901660-B Substituted bicyclic compounds useful as T cell activators 百时美施贵宝公司 2024-10-15 — — CN disclosed
Send feedback